Biote Corp (BTMD)
5.88
-0.07
(-1.18%)
USD |
NASDAQ |
May 15, 15:34
Biote Cash from Operations (TTM): 21.26M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 21.26M |
December 31, 2023 | 26.88M |
September 30, 2023 | 25.98M |
Date | Value |
---|---|
June 30, 2023 | 32.21M |
March 31, 2023 | -3.134M |
December 31, 2022 | -9.157M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.157M
Minimum
Dec 2022
32.21M
Maximum
Jun 2023
15.67M
Average
23.62M
Median
Cash from Operations (TTM) Benchmarks
Teladoc Health Inc | 345.78M |
American Shared Hospital Services | 5.718M |
Novo Integrated Sciences Inc | -4.952M |
Astrana Health Inc | 66.48M |
Cryo-Cell International Inc | 6.919M |